B&L Expanded Drug-Delivery Products Seen As Springboard To Future Growth
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb continues to transform itself into a drug-delivery eyecare company from a traditional contact lens firm, with implants and molecular compounds in various stages of development